Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001179110-21-009610
Filing Date
2021-10-25
Accepted
2021-10-25 17:30:36
Documents
1
Period of Report
2021-10-22

Document Format Files

Seq Description Document Type Size
1 FORM 4 - edgar.html 4  
1 FORM 4 - edgar.xml 4 3036
  Complete submission text file 0001179110-21-009610.txt   4508
Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104 267-225-7416
Context Therapeutics Inc. (Issuer) CIK: 0001842952 (see all company filings)

EIN.: 472566423 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address 3675 MARKET STREET SUITE 200 PHILADELPHIA PA 19104
Business Address
Levit Alex C. (Reporting) CIK: 0001862840 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-40654 | Film No.: 211345128